These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15593433)

  • 21. Radiation exposure from CT-guided ablation of renal masses: effects on life expectancy.
    Eisenberg JD; Gervais DA; Singh S; Kalra MK; Sabir SH; Paul AB; Pandharipande PV
    AJR Am J Roentgenol; 2015 Feb; 204(2):335-42. PubMed ID: 25615756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of General Anesthesia and Conscious Sedation During Computed Tomography-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma.
    Kim HJ; Park BK; Chung IS
    Can Assoc Radiol J; 2018 Feb; 69(1):24-29. PubMed ID: 29198818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
    Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
    AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy.
    Javadi S; Matin SF; Tamboli P; Ahrar K
    J Vasc Interv Radiol; 2007 Sep; 18(9):1186-91. PubMed ID: 17804784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-guided radiofrequency ablation of a renal tumor abutting vascular pedicle in a patient with von Hippel Lindau disease.
    Park BK; Kim CK
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):840-2. PubMed ID: 19067041
    [No Abstract]   [Full Text] [Related]  

  • 29. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results.
    Mahnken AH; Rohde D; Brkovic D; Günther RW; Tacke JA
    Acta Radiol; 2005 Apr; 46(2):208-14. PubMed ID: 15902899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors for complete renal tumor ablation using RFA.
    Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
    Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.
    Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA
    J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
    Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
    J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation of renal cell carcinoma in patients with a solitary kidney: a retrospective analysis of our experience.
    Grasso RF; Luppi G; Faiella E; Giurazza F; Del Vescovo R; Cazzato RL; Beomonte Zobel B
    Radiol Med; 2012 Jun; 117(4):606-15. PubMed ID: 22095427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
    Goeman L; Joniau S; Oyen R; Van Poppel H
    Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax.
    Ahrar K; Matin S; Wallace MJ; Gupta S; Hicks ME
    AJR Am J Roentgenol; 2005 Jul; 185(1):86-8. PubMed ID: 15972404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up.
    Chan P; Vélasco S; Vesselle G; Boucebci S; Herpe G; Debaene B; Ingrand P; Irani J; Tasu JP
    Clin Radiol; 2017 Sep; 72(9):786-792. PubMed ID: 28545682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.